Clinical Trial: Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa

U.S., May 7 -- ClinicalTrials.gov registry received information related to the study (NCT06958211) titled 'Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa' on April 25.

Brief Summary: The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in participants with hidradenitis suppurativa.

Study Start Date: June 11

Study Type: INTERVENTIONAL

Condition: Hidradenitis Suppurativa

Intervention: DRUG: Ruxolitinib Cream

Ruxolitinib cream applied topically to the affected area as a thin film twice daily.

DRUG: Vehicle Cream

Matching vehicle cream applied topically to the affected area as a thin film twice daily.

Recruitment Status: NOT_YET_RECRUITING...